We will also collect serum samples from additional esophageal cancer patients on day 7 after radiotherapy initiation and develop models to predict the radiotherapy response based on early changes in the circulating let-7a and IL-6 levels observed during radiotherapy. This evidence concerns the gene IL6 and esophageal cancer.